Dr. Hiram A Gay, M.D.
Claim this profileWashington University School of Medicine
Studies Prostate Cancer
Studies Cancer
15 reported clinical trials
31 drugs studied
Area of expertise
1Prostate Cancer
Stage I
Stage II
White blood cell count (WBC)
2Cancer
Stage IV
Stage III
p16 positive
Affiliated Hospitals
Clinical Trials Hiram A Gay, M.D. is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
More about Hiram A Gay, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Hiram A Gay, M.D. has experience with
- Radium-223 Dichloride
- Cabozantinib
- Avelumab
- Stereotactic Body Radiation Therapy
- Salvage Radiotherapy
- Enzalutamide
Breakdown of trials Hiram A Gay, M.D. has run
Prostate Cancer
Cancer
Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hiram A Gay, M.D. specialize in?
Hiram A Gay, M.D. focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage I patients, or patients who are Stage II.
Is Hiram A Gay, M.D. currently recruiting for clinical trials?
Yes, Hiram A Gay, M.D. is currently recruiting for 9 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Hiram A Gay, M.D. has studied deeply?
Yes, Hiram A Gay, M.D. has studied treatments such as Radium-223 Dichloride, Cabozantinib, Avelumab.
What is the best way to schedule an appointment with Hiram A Gay, M.D.?
Apply for one of the trials that Hiram A Gay, M.D. is conducting.
What is the office address of Hiram A Gay, M.D.?
The office of Hiram A Gay, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.